Congratulations to Lylia Azoug for her poster prize!

Lylia Azoug, PhDstudent in the “Synthetic protein and bioorthogonal chemistry” team, received the poster prize during the “Chemical Biology Symposium 2024” conference organized by the Société Chimique de France.

 

Poster abstract :

Generation of specific antibodies against peptides requires their covalent conjugation to large protein carriers, such as keyhole limpet hemocyanin (KLH), to override their inherently weak immunogenicity. For this, most approaches exploit the highly-efficient thiol-maleimide ligation, which enables for the attachment of multiple copies of peptides displaying a single cysteine thiol group, onto a variety of commercial maleimide-functionalized carriers. Concerning disulfide-containing peptides and proteins, introduction of a spare thiol moiety permits a follow-up thiol-maleimide reaction; nevertheless, disulfide bonds are highly susceptible to undergo intramolecular thiophilic attack by the thiolate required for the reaction, with consequent impairing of their native bridging framework. This “disulfide scrambling” would alter the peptide 3D structure, impairing specificity of elicited antibodies for the native target. In recent reports, thiol-functionalized spacers were introduced on disulfide-containing peptides to generate protein conjugates for immunization purposes, 1,2 nevertheless the occurrence of disulfide scrambling was not examined, therefore we sought to systematically evaluate the influence of different thiol-functionalized spacers. Using the N-terminal domain of the Lingo1 protein as a model peptide (20 amino acids, 2 disulfide bridges), we probed a small battery of thiol-containing spacers with variable length and rigidity. Interestingly, while flexible linkers, comparable with previously described ones,1,2 showed considerable disulfide scrambling upon 2 h under thiol-maleimide reaction conditions (pH 6.6), a short and rigid oligoproline-based linker3 abolished the disruption of the disulfide framework. The reported strategy provides a valuable resource for the bioconjugation of disulfide-containing peptides via standard thiol-maleimide chemistry while maintaining the structural integrity of the disulfide framework, thereby providing homogeneous tools for research and biomedical applications.

  1. Katayama, H.; Mita, M. A sulfanyl-PEG derivative of relaxin-like peptide utilizable for the conjugation with KLH and the antibody production. Bioorganic & ; Med. Chem. 2016, 24 (16), 3596–3602. DOI : 10.1016/j.bmc.2016.05.068
  2. Katayama, H.; Mizuno, R.; Mita, M. A novel approach for preparing disulfide-rich peptide-KLH conjugate applicable to the antibody production. Biosci. Biotechnol. Biochem2019, 83 (10), 1791–1799. DOI : 10.1080/09168451.2019.1618696
  3. Wilhelm, P.; Lewandowski, B.; Trapp, N.; Wennemers, H. A Crystal Structure of an Oligoproline PPII-Helix, at Last.J. Am. Chem. Soc2014, 136 (45), 15829–15832. DOI : 10.1021/ja507405j

Comprehensive review about the “logic of protein modifications”

Among the main functional building blocks of living cells are proteins, small “molecular machines” produced by the cell according to the information encoded in genes. Each protein has its characteristic chemical composition which defines its structure and function.

In some circumstances, the chemical composition of a protein can be changed in an enzymatic process known as post-translational modification (PTM), whereby additional chemical groups are covalently attached to the protein. PTMs are used by the cell as a regulatory mechanism to control protein function. The addition of new chemical groups – which can come in different shapes and sizes, ranging from small groups, through sugars and lipids, to small proteins – changes the structure and interactions of a protein and can impact almost any aspect of its function.

Marcin Suskiewicz, a structural biologist and biochemist from the CBM, has devoted many years to studying various types of protein PTMs and currently supervises a project devoted to one particular type of PTMs, protein SUMOylation.

In the review published in the journal BioEssays, he reviews the history of the research into protein PTMs as well as various facets of this phenomenon, including the underlying chemical principles, molecular mechanisms, and evolution.

The review combines an introduction to the field with an overview of the recent literature and new ideas and hypotheses.

References:

The logic of protein post-translational modifications (PTMs): Chemistry, mechanisms and evolution of protein regulation through covalent attachments
Marcin Suskiewicz
BioEssays
First published:21 January 2024
https://doi-org.insb.bib.cnrs.fr/10.1002/bies.202300178

Research on glioma (brain tumor) carried out at the CBM highlighted by CNRS Chimie

The use of different original NMR methods (MRI, 1H HR-MAS, 2D liquid NMR) made it possible to characterize a glioma model established in adult Drosophila and to reveal the therapeutic potential of a serotonin receptor for the treatment of these cancers.

Read the CNRS Chimie article.

Read the "Actualité chimique" article n° 492, 2024, February

Gliomas account for 50% of brain cancers and therefore constitute the most common brain tumors. Molecular alterations involved in adult gliomas have been identified and mainly affect tyrosine kinase receptors with amplification and/or mutation of the epidermal growth factor receptor (EGFR) and its associated signaling pathways. Several targeted therapies have been developed but current treatments remain ineffective for glioblastomas, the most severe forms. Thus, it is a priority to identify new pharmacological targets. Here, we used a Drosophila glioma model in adult, to characterize metabolic disturbances associated with glioma and assess the consequences of the serotonin 5-HT7 receptor expression on glioma development. First, by using in vivo Magnetic Resonance Imaging, we have shown that expression of the constitutively active forms of EGFR and PI3K in adult glial cells induced enlargement of brains. Then, we explored altered cellular metabolism by using High-Resolution Magic Angle Spinning NMR and 1H-13C Heteronuclear Single Quantum Coherence solution state. Discriminant metabolites identified highlight rewiring of metabolic pathways in glioma, and associated cachexia phenotypes. Finally, the expression of 5-HT7R in this model attenuates phenotypes associated with glioma development (brain enlargement and cachexia).

Article :
An adult Drosophila glioma model to highlight metabolic dysfunctions and evaluate the role of the serotonin 5-HT7 receptor as a potential therapeutic target.
Bertrand M, Szeremeta F, Hervouet‐Coste N, Sarou-Kanian V, Landon C, Morisset-Lopez S, Decoville M
The FASEB Journal. 2023 37:e23230. doi:10.1096/fj.202300783RR

A review on ADP-ribosylation appeared in the journal Cell

ADP-ribosylation is a biochemical reaction in which the ADP-ribose group from NAD+ becomes covalently attached to various substrates. As such, ADP-ribosylation represents a ubiquitous modification of proteins and other biomolecules (e.g., nucleic acids). Catalysed by a range of specific enzymes, the most important of which in humans is PARP1, ADP-ribosylation serves as a regulatory mechanism influencing a wide array of cellular processes in all domains of life. This new review, published in the authoritative Leading Edge series of reviews of the journal Cell, covers the state of the art on this subject spanning structural biology, biochemistry, cell biology, and the clinical facets of ADP-ribosylation. In addition to Marcin Suskiewicz from the CBM as the first author, the review was co-authored by Ivan Ahel and members of his group at the University of Oxford.

Suskiewicz M., Prokhlrova E., Rack J.G.M., Ahel I.
ADP-ribosylation from molecular mechanisms to therapeutic implications
Cell Review, Volume 186, Issue 21, pages 4475-4495, October 12, 2023 - doi: 10.1016/j.cell.2023.08.03